Stocks in Focus on June 11: SAIL, Accelya Solutions, Marksans Pharma, Godrej Properties to Puravankara; here are the 5 Newsmakers of the Day
The Sensex and the Nifty on Thursday, June 10, 2021, rose more than half a per cent amid positive Asian cues. The Sensex closed above the 52,000 mark while the Nifty settled above the 15,700 level.
The Sensex and the Nifty on Thursday, June 10, 2021, rose more than half a per cent amid positive Asian cues. The Sensex closed above the 52,000 mark while the Nifty settled above the 15,700 level. The S&P BSE Sensex climbed 359 points, or 0.69 per cent, to finish at 52,300. The Nifty 50 also surged 102 points, or 0.65 per cent, to close at 15,738. But certain stocks came in the news after the market was closed. These stocks can impact the indices, when it reopens on Friday, June 11, 2021. List of such five stocks:
See Zee Business Live TV Streaming Below:
SAIL + eClerx + NHPC
SAIL: The state-owned steel production company has reported a 136.37% QoQ rise in the consolidated profit at Rs 3,470 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 1,468 crore in the previous quarter ended December 31, 2021. Consolidated revenue grew 17% to Rs 23,285 crore in the reported quarter compared to Rs 19,836 crore posted in the previous quarter. EBITDA stood at Rs 6,153 crore, 21% up from Rs 5,080 crore posted in the December quarter. The adjusted EBITDA stood at Rs 7,303 crore against an estimated EBIDTA of Rs 6,592 crore. The margin improved to 26.4% in Q4FY21 compared to Rs 25.6% posted in Q3FY21. Adjusted Margin stood at 31.4% against an estimated margin of 28.6%.
eClerx Services: (NAKK Stock). The IT consulting and outsourcing company eClerx has reported an 80% YoY rise in the consolidated profit at Rs 99 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 55 crore in the corresponding quarter of the previous financial year. Revenue from operations grew 34.8% to Rs 473 crore in the reported quarter compared to Rs 351 crore posted last year. The EBITDA stood at Rs 153 crore, up 97.4% from Rs 77.5 crore posted last year. EBITDA margin improved to 32.3% in Q4FY21 from 22.1% posted in Q4FY20. The board has recommended a dividend of Rs 1 per share.
NHPC: The state-owned NHPC has reported a 172.6% YoY rise in the consolidated profit at Rs 428 crore for the quarter ended March 31, 2021. It has posted a profit of Rs 157 crore in the corresponding quarter of the previous financial year. Consolidated revenue from operations fell 25.9% YoY to Rs 1,609 crore in the reported quarter compared to Rs 2,170 crore posted last year. The EBITDA stood at Rs 548 crore, down 22.9% from Rs 711 crore posted last year. EBITDA Margin improved to 34.1% in Q4FY21 compared to 32.8% posted in Q4FY20. The board has recommended a final dividend of Rs 3.5/share. It also approved a fundraising plan of Rs 4,300 crore.
Accelya OFS update + Yes Bank
Accelya Solutions India Limited: The non-retail portion of the offer for sale (OFS) was subscribed 4.36 times on the first day of subscription. The offer will open for retail investors for subscription today. Accelya Group Bidco Limited, promoter of the company, proposed to sell up to 21.82 lakh equity shares through an offer for sales (OFS). The floor price for the offer shall be Rs 910 per share.
Yes Bank: The board of directors of private sector lender YES Bank has approved seeking shareholders’ approval for raising up to Rs 10,000 crore in Indian or foreign currency by issuing debt securities, including but not limited to non-convertible debentures, bonds and medium-term notes.
Marksans + Suven
Marksans Pharma: The Board of Directors of the Company is scheduled to meet on June 15, 2021, to consider and approve the issuance of convertible warrants on a preferential basis. OrbiMed Asia IV Mauritius can buy 4.93 crore warrants worth Rs 365 crore in the company. It is going to be one of the largest pharma funds.
Suven Pharma Ltd: Suven Pharmaceuticals Ltd., (SPL), CSIR-Indian Institute of Chemical Technology, Hyderabad and CSIR-National Institute of Interdisciplinary Science & Technology, Thiruvananthapuram have entered into an agreement for the process technology transfer and manufacturing of the anti-COVID drug, Molnupiravir and 2-DG. It is a related party transaction as one of our Independent Directors Dr S Chandrasekhar is the Director of CSIR-IICT, Hyderabad. The agreements between the parties involve a total fee of Rs 8 lakh plus taxes for the grant of the licenses on a non-exclusive basis to SPL.
Godrej Properties + Puravankara
Godrej Properties: Godrej Projects Development, a wholly-owned subsidiary of the company has acquired 20% issued and paid-up share capital of Vagishwari Land Developers. Godrej Projects Development Limited along with other investors intends to develop a real estate project on the land owned by VLDPL.
Puravankara Limited: The company has successfully completed the transaction of sale of shares of its 100% subsidiary- Vagishwari Land Developers Private Limited and received a sum of approx. Rs 150 crore from the purchasers of shares namely GBTC II (Asset A) PTE Ltd and Godrej Projects Development Limited. Further, the company has also received the outstanding amount of approx. Rs 350 crore from Vagishwari Land Developers Private Limited.
Promoter Actions
Laurus Labs: Promoters (Chunduru Rao and Ravi Vantaram) sold 8 lakh shares between June 8-9.
Aarti Industries: Promoters (Shreya Suneja and Sarla Shah) sold 55,500 shares between June 7-9.
Kalyani Investment Company: Promoter Ajinkya Investment and Trading Company bought 24,113 shares on June 9.
Man Infraconstruction: Promoter Parag Shah bought 2.50 lakh shares on June 9.
Nelcast: Promoter P Deepak bought 20,000 shares on June 9.
Panama Petrochem: Promoter Ittefaq Ice & Cold Storage Company bought 24,068 shares on June 9.
Ultramarine & Pigments: Promoters (S Narayan, Sridhar Sundararajan and Jayalakshmi Venkataraman) sold 41,516 shares on June 9.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.